3 Results for "

CGS 25019C

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "CGS 25019C" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-106929
CAS No.: 146978-48-5
Purity:  99.83%
Synonyms: CGS 25019C free base
Target:  

Leukotriene Receptor

Research Areas:  

Inflammation/Immunology

Moxilubant (CGS 25019C free base) is an orally active BLT1 antagonist. Moxilubant inhibits LTB4 signaling with a potency of 2-4 nM. Moxilubant blocks LTB4-induced neutrophil functions. Moxilubant inhibits ear edema and neutrophil infiltration in mice. Moxilubant can be used in research related to chronic obstructive pulmonary disease .
loading...
    loading...
Cat. No.: HY-106929B
CAS No.: 146957-32-6
Synonyms: CGS 25019C hydrochloride
Target:  

Leukotriene Receptor

Research Areas:  

Inflammation/Immunology

Moxilubant (CGS 25019C) hydrochloride is an orally active BLT1 antagonist. Moxilubant hydrochloride inhibits LTB4 signaling with a potency of 2-4 nM. Moxilubant hydrochloride blocks LTB4-induced neutrophil functions. Moxilubant hydrochloride inhibits ear edema and neutrophil infiltration in mice. Moxilubant hydrochloride can be used in research related to chronic obstructive pulmonary disease .
loading...
    loading...
Cat. No.: HY-106929R
CAS No.: 146978-48-5
Synonyms: CGS 25019C free base (Standard)
Moxilubant (CGS 25019C free base) Standard is the analytical standard of Moxilubant (HY-106929). This product is intended for research and analytical applications. Moxilubant (CGS 25019C free base) is an orally active BLT1 antagonist. Moxilubant inhibits LTB4 signaling with a potency of 2-4 nM. Moxilubant blocks LTB4-induced neutrophil functions. Moxilubant inhibits ear edema and neutrophil infiltration in mice. Moxilubant can be used in research related to chronic obstructive pulmonary disease .
loading...
    loading...